Proteins that bind methylated DNA and human cancer: Reading the wrong words

British Journal of Cancer

Volumn 98, Issue 12, 2008, Pages 1881-1885

  Lopez Serra, L ^a,b   Esteller, M ^a,b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

DNA methylation; Epigenetics; Methyl CpG binding domain proteins

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENE PRODUCT; HISTONE; METHYL CPG BINDING PROTEIN 2; NUCLEAR FACTOR; PROTEIN MBD1; PROTEIN MBD3; PROTEIN MBD4; PROTEIN P21;

CANCER GROWTH; CHROMATIN; CHROMOSOMAL INSTABILITY; CPG ISLAND; DNA METHYLATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; GENE TARGETING; GENOME IMPRINTING; HOMEOSTASIS; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; SHORT SURVEY; TISSUE SPECIFICITY; X CHROMOSOME INACTIVATION;

CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; PROTEIN BINDING; PROTEINS;

EID: 44949233068     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604374     Document Type: Short Survey

References (38)

1. Bakker J, Lin X, Nelson WG (2002) Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J Biol Chem 277(25): 22573-22580
2. Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, Espada J, Cigudosa JC, Huang TH, Esteller M (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22(23): 6335-6345
3. Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi M, Neri G (1999) MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA 96(7): 3969-3974
4. Bernard D, Gil J, Dumont P, Rizzo S, Monté D, Quatannens B, Hudson D, Visakorpi T, Fuks F, de Launoit Y (2006) The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene 25(9): 1358-1366
5. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M (1999) A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397(6720): 579-583
6. Daniel JM, Spring CM, Crawford HC, Reynolds AB, Baig A (2002) The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res 30(13): 2911-2919
7. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358(11): 1148-1159
8. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61(8): 3225-3229
9. Fabbrizio E, El Messaoudi S, Polanowska J, Paul C, Cook JR, Lee JH, Negre V, Rousset M, Pestka S, Le Cam A, Sardet C (2002) Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Rep 3(7): 641-645
10. Fatemi M, Wade P (2006) MBD family proteins: reading the epigenetic code. J Cell Sci 119(15): 3033-3037
11. Filion GJ, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez PA (2006) A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 26(1): 169-181
12. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31(6): 1765-1774
13. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37(4): 391-400
14. Fujita N, Shimotake N, Ohki I, Chiba T, Saya H, Shirakawa M, Nakao M (2000) Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol 20(14): 5107-5118
15. Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, Nakao M (2003) Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 278: 24132-24138
16. Fuks F, Hurd PJ, Wolf D, Nan X, Bird A, Kouzarides T (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278(6): 4035-4040
17. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27(3): 322-326
18. Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18(11): 6538-6547
19. Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A (2001) Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 15(6): 710-723
20. Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY (2005) Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14: 2474-2480
21. Klose RJ, Bird A (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31(2): 89-97
22. Kn H, Bassal S, Tikellis C, El-Osta A (2004) Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL). Cancer Biol Ther 3(10): 989-994
23. Kondo E, Gu Z, Horii A, Fukushige S (2005) The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol Cell Biol 25(11): 4388-4396
24. Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA, Cohen A, Lasonder E, Stunnenberg HG (2006) MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 26(3): 843-851
25. Lopez-Serra L, Ballestar E, Fraga MF, Alaminos M, Setien F, Esteller M (2006) A profile of Methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG Islands of tumor suppressor genes in human cancer. Cancer Res 66(17): 8342-8346
26. López-Serra L, Ballestar E, Ropero S, Setien F, Billard LM, Fraga MF, Lopez-Nieva P, Alaminos M, Guerrero D, Dante R, Esteller M (2008) Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of Methyl-CpG binding domain proteins. Oncogene. PMID: 18223687 [e-pub ahead of print].
27. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043): 834-838
28. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67(4): 1424-1429
29. Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A (2002) Enhanced CpG mutability and tumourigenesis in MBD4-deficient mice. Science 297(5580): 403-405
30. Muller HM, Fiegl H, Goebel G, Hubalek MM, Widschwendter A, Muller-Holzner E, Marth C, Widschwendter M (2003) MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer 89: 1934-1939
31. Prokhortchouk A, Sansom O, Selfridge J, Caballero IM, Salozhin S, Aithozhina D, Cerchietti L, Meng FG, Augenlicht LH, Mariadason JM, Hendrich B, Melnick A, Prokhortchouk E, Clarke A, Bird A (2002) Kaiso-deficient mice show resistance to intestinal cancer. Mol Cell Biol 26(1): 199-208
32. Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE, Ruggeri BA, Klein-Szanto AJ, Testa JR, Neri G, Bellacosa A (1999) The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23(3): 266-268
33. Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz M, Palacios J, Arango D, Orntoft TF, Aaltonen LA, Schwartz Jr S, Esteller M (2006) A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 38(5): 566-569
34. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9(6): 435-443
35. Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A, Clarke AR (2003) Deficiency of Mbd2 suppresses intestinal tumourigenesis. Nat Genet 34(2): 145-147
36. Zabkiewicz J, Clarke AR (2004) DNA damage-induced apoptosis: insights from the mouse. Biochim Biophys Acta 1705(1): 17-25
37. Zhou H, Harrington J, Rego RL, Ahlquist DA (2007) A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening. Clin Chem 53(9): 1646-1651
38. Zhu Y, Brown HN, Zhang Y, Holford TR, Zheng T (2005) Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status. Breast Cancer Res 7(5): 745-752